Source map — FDA appears to pause controversial speedy review program, complete response letter disclosures
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Reuters | news | 60% |
| Fierce Pharma | news | 60% |
| pharmaphorum | news | 60% |
| BioSpace | news | 60% |
| RAPS | news | 60% |
| Endpoints News | news | 60% |
| www.myasset.com | news | 50% |